BRCA2 genetic mutation associated with improved survival and chemotherapy response in ovarian cancer
Tuesday, October 11, 2011 - 16:30
in Health & Medicine
Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA wild-type (genetic type used as a reference to compare genetic mutations), according to a new study.